Regulatory Story
Go to market news section View chart   Print
RNS
Xaar PLC  -  XAR   

Director/PDMR Shareholding

Released 15:16 19-Apr-2013

RNS Number : 8193C
Xaar PLC
19 April 2013
 

Xaar plc (the "Company")

Director/PDMR Shareholding - SIP Purchase

The Company announces that as a result of purchases of ordinary shares of 10 pence each in the Company ("Ordinary Shares") at a price of 473 pence per Ordinary Share by the Xaar plc Share Incentive Plan (the "SIP") on 17 April 2013, four Executive Directors acquired the following number of Ordinary Shares in the Company:

 

Name of Director

2012 Bonus invested in the SIP

No. of Ordinary Shares acquired by the SIP as Partnership shares using the 2012 Bonus

 

No. of Ordinary Shares acquired by the

SIP as Matching share awards

Total No. of Ordinary Shares acquired through the SIP

Total beneficial interest in Ordinary Shares of Xaar plc following the SIP acquisition

% beneficial interest held in Xaar plc following the SIP acquisition

Alex Bevis

£1,500

317

317

634

38,136

0.05%

Ted Wiggans

£1,500

317

317

634

2,634

0.00%

Richard Barham

£1,500

317

317

634

6,634

0.01%

Ramon Borrell

£1,500

317

317

634

178,851

0.24%

 

 

In accordance with the terms of the SIP, the persons named above were awarded Matching shares equal to the number of Partnership shares purchased. The Matching shares will vest on the third anniversary of the date of the award subject to continued employment for those three years.

 

All of the shares purchased by the SIP were acquired via transfer from the Xaar plc ESOP.

 

 

Enquiries:

Xaar plc          

Alex Bevis - Finance Director                                                                         01223 423 663

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFLSSEIALIV
Close


London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

 


Director/PDMR Shareholding - RNS